Ghent University Academic Bibliography

Advanced

Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)

Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, Jessica Menis, Sanjay Popat, Jan Van Meerbeeck UGent, Veerle Surmont UGent, Paul Baas and Mary O'Brien (2016) EUROPEAN JOURNAL OF CANCER. 54. p.35-39
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
Phase II study, Targeted therapy, Second-line treatment, CHEMOTHERAPY, MAINTENANCE SUNITINIB, Tyrosine kinase inhibitor, Sunitinib, SCLC
journal title
EUROPEAN JOURNAL OF CANCER
Eur. J. Cancer
volume
54
pages
35 - 39
Web of Science type
Article
Web of Science id
000369150000005
JCR category
ONCOLOGY
JCR impact factor
6.029 (2016)
JCR rank
34/217 (2016)
JCR quartile
1 (2016)
ISSN
0959-8049
DOI
10.1016/j.ejca.2015.10.016
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
7147042
handle
http://hdl.handle.net/1854/LU-7147042
date created
2016-03-15 10:03:27
date last changed
2016-12-19 15:39:00
@article{7147042,
  author       = {Abdelraouf, Fatma and Smit, Egbert and Hasan, Baktiar and Menis, Jessica and Popat, Sanjay and Van Meerbeeck, Jan and Surmont, Veerle and Baas, Paul and O'Brien, Mary},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  keyword      = {Phase II study,Targeted therapy,Second-line treatment,CHEMOTHERAPY,MAINTENANCE SUNITINIB,Tyrosine kinase inhibitor,Sunitinib,SCLC},
  language     = {eng},
  pages        = {35--39},
  title        = {Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)},
  url          = {http://dx.doi.org/10.1016/j.ejca.2015.10.016},
  volume       = {54},
  year         = {2016},
}

Chicago
Abdelraouf, Fatma, Egbert Smit, Baktiar Hasan, Jessica Menis, Sanjay Popat, Jan Van Meerbeeck, Veerle Surmont, Paul Baas, and Mary O’Brien. 2016. “Sunitinib (SU11248) in Patients with Chemo Naive Extensive Small Cell Lung Cancer or Who Have a ‘Chemosensitive’ Relapse: a Single-arm Phase II Study (EORTC-08061).” European Journal of Cancer 54: 35–39.
APA
Abdelraouf, F., Smit, E., Hasan, B., Menis, J., Popat, S., Van Meerbeeck, J., Surmont, V., et al. (2016). Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a “chemosensitive” relapse: a single-arm phase II study (EORTC-08061). EUROPEAN JOURNAL OF CANCER, 54, 35–39.
Vancouver
1.
Abdelraouf F, Smit E, Hasan B, Menis J, Popat S, Van Meerbeeck J, et al. Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a “chemosensitive” relapse: a single-arm phase II study (EORTC-08061). EUROPEAN JOURNAL OF CANCER. 2016;54:35–9.
MLA
Abdelraouf, Fatma, Egbert Smit, Baktiar Hasan, et al. “Sunitinib (SU11248) in Patients with Chemo Naive Extensive Small Cell Lung Cancer or Who Have a ‘Chemosensitive’ Relapse: a Single-arm Phase II Study (EORTC-08061).” EUROPEAN JOURNAL OF CANCER 54 (2016): 35–39. Print.